Symbol
ERNA on Nasdaq
Investment type
Equity / Common Stock, par value $0.005 per share
Latest Disclosed Shares Owned
6,211,530 shares
Security Ownership %
9.9%

Freebird Partners LP ownership in Ernexa Therapeutics Inc. Common Stock, par value $0.005 per share (ERNA)

14 May 2025 - Freebird Partners LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 6,211,530 shares of Ernexa Therapeutics Inc. Common Stock, par value $0.005 per share (ERNA). This represents 9.9% ownership of the company. In their previous filing dated 28 Jan 2025, Freebird Partners LP had reported owning 5,136,696 shares, indicating an increase of +21%. .